HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision. 2008

Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
Viral Mutation Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

We previously proposed that mutations in the connection subdomain (cn) of HIV-1 reverse transcriptase increase AZT resistance by altering the balance between nucleotide excision and template RNA degradation. To test the predictions of this model, we analyzed the effects of previously identified cn mutations in combination with thymidine analog mutations (D67N, K70R, T215Y, and K219Q) on in vitro RNase H activity and AZT monophosphate (AZTMP) excision. We found that cn mutations G335C/D, N348I, A360I/V, V365I, and A376S decreased primary and secondary RNase H cleavages. The patient-derived cns increased ATP- and PPi-mediated AZTMP excision on an RNA template compared with a DNA template. One of 5 cns caused an increase in ATP-mediated AZTMP excision on a DNA template, whereas three cns showed a higher ratio of ATP- to PPi-mediated excision, indicating that some cn mutations also affect excision on a DNA substrate. Overall, the results strongly support the model that cn mutations increase AZT resistance by reducing template RNA degradation, thereby providing additional time for RT to excise AZTMP.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D016296 Mutagenesis Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS. Mutageneses
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D017931 DNA Primers Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques. DNA Primer,Oligodeoxyribonucleotide Primer,Oligodeoxyribonucleotide Primers,Oligonucleotide Primer,Oligonucleotide Primers,Primer, DNA,Primer, Oligodeoxyribonucleotide,Primer, Oligonucleotide,Primers, DNA,Primers, Oligodeoxyribonucleotide,Primers, Oligonucleotide

Related Publications

Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
November 2011, Antiviral research,
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
February 2015, Nucleic acids research,
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
August 2021, Vaccines,
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
April 2017, Virus research,
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
March 1999, Journal of molecular biology,
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
October 1997, Proceedings of the National Academy of Sciences of the United States of America,
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
December 2013, Nature structural & molecular biology,
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
December 1989, Science (New York, N.Y.),
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
January 1990, Disease markers,
Krista A Delviks-Frankenberry, and Galina N Nikolenko, and Paul L Boyer, and Stephen H Hughes, and John M Coffin, and Abhay Jere, and Vinay K Pathak
December 2010, The Journal of biological chemistry,
Copied contents to your clipboard!